IberCanPharma will use GMP-certified facilities for the production of medical cannabis extracts. Furthermore, the extraction facilities will meet the required technical and safety regulations given by INFARMED.
IberCanPharma utilizes a state-of-the-art cold extraction process using cryo ethanol extraction technologies designed to preserve the delicate content of cannabinoids and terpenes and to provide a pure and effective product. The ethanolic extraction method offers high capacity, high production and, efficient extraction of botanical oils without thermal degradation.
IberCanPharma also intends to use subcritical and supercritical CO2 extraction when its plantation is in the maximum potential phase. The system can process up to 50 kg of decarboxylated cannabis per day. Using subcritical and supercritical CO2, the systems offer high capacity and high production operations with fast and efficient extraction of botanical oils without thermal degradation.
Participation in R&D Projects
IberCanPharma is involved in various Research& Development Projects, with the aim to constantly improve its product-portfolio.